Tower Research Capital (TRC)’s GeneDx Holdings Warrant WGSWW Stock Holding History

Tower Research Capital (TRC)’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-128	Closed	-$20	–	5856
2024 Q4	$20	Hold	128	–	–	﹤0.01%	5604
2024 Q3	$10	Hold	128	–	–	﹤0.01%	5631
2024 Q2	$4	Hold	128	–	–	﹤0.01%	5629
2024 Q1	$7	Hold	128	–	–	﹤0.01%	5790
2023 Q4	$1	Hold	128	–	–	﹤0.01%	5896
2023 Q3	$4	Hold	128	–	–	﹤0.01%	5894
2023 Q2	$1	Hold	128	–	–	﹤0.01%	6003
2023 Q1	$0	Hold	128	–	–	﹤0.01%	6330
2022 Q4	$0	Hold	128	–	–	﹤0.01%	6431
2022 Q3	$0	Hold	128	–	–	﹤0.01%	6538
2022 Q2	$0	Hold	128	–	–	﹤0.01%	6569
2022 Q1	$0	Hold	128	–	–	﹤0.01%	6587
2021 Q4	$0	Hold	128	–	–	﹤0.01%	6615
2021 Q3	$0	Buy	+128	New	+$421	﹤0.01%	6220

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Tower Research Capital (TRC)'s WGSWW Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2025, closing a stake of 128 shares — an estimated $20 sold.

Tower Research Capital (TRC) first reported a position in WGSWW in Q3 2021 and held it in 14 quarters. The position peaked at $20 in Q4 2024. 14 funds tracked by Wall St. Rank hold WGSWW as of Q1 2025.

Tower Research Capital (TRC) reported no remaining GeneDx Holdings Warrant position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 128 GeneDx Holdings Warrant shares in Q1 2025, an estimated $20.
Tower Research Capital (TRC) first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 14 quarters.
Tower Research Capital (TRC)'s GeneDx Holdings Warrant position peaked at $20 in Q4 2024.
14 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.